> Skip repeated content

HSS Research Institute

Development and Testing of the Hand Surgery Expectations Survey

IRB Number: 10021
(inactive trial)

Institutional Review Board, Hospital for Special Surgery

March 17, 2010

The safety of study participants is our top priority. The trial is approved and periodically reviewed by an Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.

Before enrolling in a clinical trial, the investigator will explain the purpose of the trial, its expected benefits, any possible risks or side effects, and what your role will be. This is the time to ask questions! If you want to join the trial, you must sign the informed consent documents. You can leave a clinical trial at any time without penalty.

For further information, see Understanding Clinical Trials.

Principal Investigator

Lana Kang, MD


Edward A. Athanasian, MD
Michelle G. Carlson, MD
Carol Mancuso, MD
Andrew J. Weiland, MD
Scott W. Wolfe, MD
Steve K. Lee, MD


The phenomenon to be studied is the expectations of patients seeking treatment for basilar joint arthritis of the hand. The basilar joint refers to the thumb carpometacarpal joint and is the most common site of arthritis treated with surgical methods.  The main reasons for seeking treatment for basilar joint arthritis are to relieve symptoms and improve function.   The study aim is to develop and to test a validated survey that measures patients’ expectations after treatment for basilar joint arthritis.  The primary form if intervention is a one-on-one interview via which data will be obtained and collected.  There will be 3 parts of the study, and the total number of patients needed for the study is 163. 

Inclusion/Exclusion Criteria

Adult English speaking patients age 18-100 seeking treatment for basilar joint arthritis

Contact Information

Lana Kang, MD